ImmunoPrecise Antibodies Ltd. ( NASDAQ: IPA) Q3 2025 Earnings Conference Call March 28, 2025 10:30 AM ET Jennifer Bath - Chief Executive Officer and President Joseph Scheffler - Interim Chief ...
Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback